References
Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot Ess Fat Acids. 1995;52:387–91.
Das UN. A defect in the activity of D6 and D5 desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot Ess Fat Acids. 2005;72:343–50.
Gromovsky AD, Schugar RC, Brown AL, Helsley RN, Burrows AC, Ferguson D, et al. Δ-5 fatty acid desaturase FADS1 impacts metabolic disease by balancing proinflammatory and proresolving lipid mediators. Arterioscler Thromb Vasc Biol. 2018;38:218–31. https://doi.org/10.1161/ATVBAHA.117.309660. Epub 2017 Oct 26.
Krishna Mohan I, Das UN. Prevention of chemically induced diabetes mellitus in experimental animals by polyunsaturated fatty acids. Nutrition. 2001;17:126–51. https://doi.org/10.1016/s0899-9007(00)00468-8.
Suresh Y, Das UN. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Prostaglandins Leukot Ess Fat Acids. 2001;64:37–52. https://doi.org/10.1054/plef.2000.0236.
Ceylan-Isik A, Hünkar T, Aşan E, Kaymaz F, Ari N, Söylemezoğlu T, et al. (Antioxidants in Diabetes-Induced Complications) The ADIC Study Group. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats. J Pharm Pharm. 2007;59:1629–41. https://doi.org/10.1211/jpp.59.12.0004.
Morimoto M, Lee EY, Zhang X, Inaba Y, Inoue H, Ogawa M, et al. Eicosapentaenoic acid ameliorates hyperglycemia in high-fat diet-sensitive diabetes mice in conjunction with restoration of hypoadiponectinemia. Nutr Diabetes. 2016;6:e213 https://doi.org/10.1038/nutd.2016.21.
Wang L, Folsom AR, Eckfeldt JH. Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults: The Atherosclerosis Risk in communities (ARIC) Study. Nutr Metab Cardiovasc Dis. 2003;13:256–66.
Zheng ZJ, Folsom AR, Ma J, Arnett DK, McGovern PG, Eckfeldt JH. Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1999;150:492–500.
Tram L, Bork CS, Venø SK, Lasota AN, Lundbye-Christensen S, Schmidt EB, et al. Intake of marine n-3 polyunsaturated fatty acids and the risk of incident peripheral artery disease. Eur J Clin Nutr, in press.
Poorani R, Bhatt AN, Dwarakanath BS, Das UN. COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance. Eur J Pharm. 2016;785:116–32.
Hashimoto K Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders. Front Pharmacol. https://doi.org/10.3389/fphar.2019.00036.
Juan H, Sametz W. Dihomo-gamma-linolenic acid increases the metabolism of eicosapentaenoic acid in perfused vascular tissue. Prostaglandins Leukot Med. 1985;19:79–86.
Hrelia S, Lopez Jimenez JA, Bordoni A, Nvarro SZ, Horrobin DF, Rossi CA, et al. Essential fatty acid metabolism in cultured rat cardiomyocytes in response to either N-6 or N-3 fatty acid supplementation. Biochem Biophys Res Commun. 1995;216:11–19.
Bordoni A, Lopez-Jimenez JA, Spanò C, Biagi P, Horrobin DF, Hrelia S. Metabolism of linoleic and alpha-linolenic acids in cultured cardiomyocytes: effect of different N-6 and N-3 fatty acid supplementation. Mol Cell Biochem. 1996;157:217–22.
Das UN. “Cell membrane theory of senescence” and the role of bioactive lipids in aging and aging associated diseases and their therapeutic implications. Biomolecules. 2021;11:241 https://doi.org/10.3390/biom11020241.
Naveen KVG, Naidu VGM, Das UN. Arachidonic acid and lipoxin A4 attenuate streptozotocin-induced cytotoxicity to RIN5F cells in vitro and type 1 and type 2 diabetes mellitus in vivo. Nutrition. 2017;35:61–80.
Bathina S, Gundala NKV, Rhenghachar P, Polavarapu S, Hari AD, Sadananda M, et al. Resolvin D1 Ameliorates Nicotinamide-streptozotocin-induced Type 2 Diabetes Mellitus by its Anti-inflammatory Action and Modulating PI3K/Akt/mTOR Pathway in the Brain. Arch Med Res. 2020;51:492–503.
Bathina S, Das UN. Resolvin D1 decreases severity of streptozotocin-induced type 1 diabetes mellitus by enhancing BDNF levels, reducing oxidative stress, and suppressing inflammation. Int J Mol Sci. 2021;22:1516.
Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol. 2008;9:873–9.
Naveen KVG, Naidu VGM, Das UN. Arachidonic acid and lipoxin A4 attenuate alloxan-induced cytotoxicity to RIN5F cells in vitro and type 1 diabetes mellitus in vivo. BioFactors. 2017;43:251–71.
Das UN. Cross talk among leukocytes, platelets, and endothelial cells and its relevance to atherosclerosis and coronary heart disease. Curr Nutr Food Sci. 2009;5:75–93.
Levin M, Leppanen O, Evaldsson M, Wiklund O, Bondjers G, Bjornheden T. Mapping of ATP, glucose, glycogen, and lactate concentrations within the arterial wall. Arterioscler Thromb Vasc Biol. 2003;25:1801–7.
Jennings RB, Kaltenbach JP, Sommens HM. Mitochondrial metabolism in ischemic injury. Arch Pathol. 1967;84:15–19.
Santerre RF, Nicolosi RJ, Smith SC. Respiratory control in preatherosclerotic susceptible and resistant pigeon aortas. Exp Mol Pathol. 1974;20:397–406.
Smith EB. The effects of age and of early atheromata on the intimal lipids in men. Biochem J. 1962;84:49.
Smith EB. Lipids carried by S1 0-12 lipoprotein in normal and hypercholesterolaemic serum. Lancet. 1962;2:530–4.
Klein PD, Johnson RM. Phosphorous metabolism in unsaturated fatty acid-deficient rats. J Biol Chem. 1954;211:103–10.
Hayashida T, Portman OW. Swelling of liver mitochondria from rats fed diets deficient in essential fatty acids. Proc Soc Exp Biol Med. 1960;103:656–9.
Cornwell DG, Panganamala RV. Atherosclerosis an intracellular deficiency in essential fatty acids. Prog Lipid Res. 1981;20:365–76.
Das UN. Essential fatty acids-a review. Curr Pharm Biotech. 2006;7:467–82.
Bhatt DL, Budoff MJ. A Revolution in omega-3 fatty acid research. JACC. 2020;7:2098–101.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Das, U.N. Bioactive lipids and vascular disease. Eur J Clin Nutr 75, 1528–1531 (2021). https://doi.org/10.1038/s41430-021-00925-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-021-00925-2
- Springer Nature Limited
This article is cited by
-
Can essential fatty acids (EFAs) prevent and ameliorate post-COVID-19 long haul manifestations?
Lipids in Health and Disease (2024)